|
Mapping cancer micro-environments for acute leukemia
|
5R01CA202025-02
|
$462,880
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Initiation of DNA Replication in Mammalian Cells
|
ZIA BC 010411
|
$936,196
|
Aladjem, Mirit
|
CCR (NCI)
|
|
Reprogramming Tumor-Associated Macrophages in PDAC with MicroRNA Nano-Vectors
|
1R21CA213114-01A1
|
$170,738
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
Immune cell control of ovarian cancer
|
ZIA BC 011775
|
$309,150
|
Annunziata, Christina
|
CCR (NCI)
|
|
Identifying vulnerabilities and therapeutic targets in Glioma Stem Cells
|
5K22CA197053-03
|
$200,880
|
BADR, CHRISTIAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Role of the Long Non-coding RNA PVT1 in Cancer
|
7R01CA200643-02
|
$446,063
|
BAGCHI, ANINDYA
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
Dusp4 in breast cancer: tumor suppressor biology and therapeutic strategies
|
5R00CA181491-04
|
$250,586
|
BALKO, JUSTIN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Histone Methyltransferases as a Target for Lung Cancer Prevention
|
5R01CA183296-04
|
$778,686
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
SPORE: Brain Tumore SPORE Grant
|
5P50CA097257-15
|
$2,300,000
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-17
|
$701,719
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cellular biofactories for therapeutic protein synthesis in tumor microenvironment
|
5R21CA193064-04
|
$240,357
|
BHATNAGAR, PARIJAT
|
SRI INTERNATIONAL
|
|
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
|
1R21CA216678-01
|
$254,475
|
BRADLEY, LINDA
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas
|
2P01CA069246-20
|
$1,387,951
|
BREAKEFIELD, XANDRA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers
|
5R33CA202900-02
|
$412,553
|
BREUNIG, JOSHUA
|
CEDARS-SINAI MEDICAL CENTER
|
|
Optimization of a clinical stage nanoparticle drug delivery platform
|
5R44CA186410-03
|
$998,609
|
BROWN, BOB
|
DICERNA PHARMACEUTICALS, INC.
|
|
Cancer Prevention and Treatment by Activation of a Brain-Adipocyte Axis
|
5R01CA166590-05
|
$319,550
|
CAO, LEI
|
OHIO STATE UNIVERSITY
|
|
Mechanisms of Chromosome Maintenance in Bacteria
|
ZIA BC 010277
|
$518,152
|
Chattoraj, Dhruba
|
CCR (NCI)
|
|
Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia
|
5R01CA182528-05
|
$336,114
|
CHEN, JIANJUN
|
UNIVERSITY OF CINCINNATI
|
|
Metabolic reprogramming of Tregs in tumor immunity
|
1R01CA221290-01
|
$410,606
|
CHI, HONGBO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia
|
5R01CA196604-03
|
$354,563
|
CHIANG, MARK
|
UNIVERSITY OF MICHIGAN
|
|
MOTILITY AND INVASION
|
5P01CA100324-15
|
$2,028,990
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Telomere Biology
|
ZIA BC 011519
|
$1,268,391
|
Cooper, Julia
|
CCR (NCI)
|
|
Lambda Genetic Networks and Lambda Red-Mediated Recombination
|
ZIA BC 010336
|
$1,316,136
|
Court, Donald
|
CCR (NCI)
|
|
Novel targeted adenovirus
|
1R01CA211096-01A1
|
$348,844
|
CURIEL, DAVID
|
WASHINGTON UNIVERSITY
|
|
Molecular Basis of Cancer Virus Replication, Transformation, and Innate Defense
|
3P01CA016038-43S1
|
$106,835
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
Molecular Basis of Cancer Virus Replication, Transformation, and Innate Defense
|
5P01CA016038-43
|
$980,728
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
Mechanisms of tumor escape from anti-angiogenic therapy
|
5R01CA177875-05
|
$330,775
|
DUDLEY, ANDREW
|
UNIVERSITY OF VIRGINIA
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$556,461
|
Feldman, Steven
|
CCR (NCI)
|
|
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery
|
5R01CA196947-02
|
$350,644
|
FIGUEIREDO, MARXA
|
PURDUE UNIVERSITY
|
|
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
|
5R35CA197452-03
|
$904,402
|
FLORES, ELSA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Targeting epigenetic regulators using bacterial macromolecule delivery
|
5R01CA188382-04
|
$308,407
|
FORBES, NEIL
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
|
Combination Gene Therapy and Th1-Th2 Therapy
|
ZIA BC 011219
|
$272,402
|
Fowler, Daniel
|
CCR (NCI)
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$776,399
|
Fry, Terry
|
CCR (NCI)
|
|
PATTERNS OF r AAV VECTOR INSERTION ASSOCIATED WITH LIVER TUMORS IN A MOUSE MODEL
|
5R01CA172713-05
|
$303,988
|
FU, HAIYAN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
Reporter Gene Technologies for Integrated Cancer Diagnostics
|
5R01CA082214-17
|
$375,250
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
|
Mechanisms in Polyomavirus Assembly
|
5R01CA037667-33
|
$371,424
|
GARCEA, ROBERT
|
UNIVERSITY OF COLORADO
|
|
Enhancing Immunological Memory Using Aptamertargeted siRNA Delivery to T Cells
|
3R01CA181598-04S1
|
$100,813
|
GILBOA, ELI
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Enhancing Immunological Memory Using Aptamertargeted siRNA Delivery to T Cells
|
5R01CA181598-04
|
$318,513
|
GILBOA, ELI
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Targeting melanoma hypoxia with lactic acid bacterium L. lactis
|
1R21CA210202-01A1
|
$200,970
|
GOMEZ-GUTIERREZ, JORGE
|
UNIVERSITY OF LOUISVILLE
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$587,732
|
Gottesman, Michael
|
CCR (NCI)
|
|
Nanoparticle modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer
|
5R01CA195503-02
|
$10,280
|
GREEN, JORDAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Liver Cancer Risk with rAAV Gene Therapy
|
5R01CA190144-03
|
$585,925
|
GROMPE, MARKUS
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Mechanism, Regulation and Application of miRNA pathway in cancer
|
ZIA BC 011566
|
$686,859
|
Gu, Shuo
|
CCR (NCI)
|
|
RNA Therapeutics for Targeted Treatment of Colon Cancer
|
5R01CA186100-04
|
$341,702
|
GUO, BIN
|
UNIVERSITY OF HOUSTON
|
|
Leveraging Genetically-Engineered Mice to Optimize Pediatric Glioma Management
|
5R01CA195692-03
|
$551,530
|
GUTMANN, DAVID
|
WASHINGTON UNIVERSITY
|
|
Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors
|
5R01CA204968-02
|
$512,053
|
HANES, JUSTIN
|
JOHNS HOPKINS UNIVERSITY
|
|
Exploring the therapeutic potential and pathogenic contribution of MTAP deletion in Glioblastoma
|
1F30CA206336-01A1
|
$35,090
|
HANSEN, LANDON
|
DUKE UNIVERSITY
|
|
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer
|
5R01CA175318-03
|
$354,563
|
HATEFI, ARASH
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
Efficient Delivery of Plasmid DNA to Achieve Appropriate Transgene Expression
|
5R01CA186730-03
|
$353,892
|
HELLER, RICHARD
|
OLD DOMINION UNIVERSITY
|
|
DNA-specific pattern recognition receptor activation following DNA electroporation
|
5R01CA196796-02
|
$316,169
|
HELLER, LOREE
|
OLD DOMINION UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|